acetaminophen has been researched along with Pneumonia, Viral in 10 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sodhi, M | 1 |
| Etminan, M | 1 |
| Rodríguez-Morales, AJ | 1 |
| Cardona-Ospina, JA | 1 |
| Murillo-Muñoz, MM | 1 |
| Gasbarrini, G | 1 |
| Della-Torre, E | 1 |
| Della-Torre, F | 1 |
| Kusanovic, M | 1 |
| Scotti, R | 1 |
| Ramirez, GA | 1 |
| Dagna, L | 1 |
| Tresoldi, M | 1 |
| Crighton, AJ | 1 |
| McCann, CT | 1 |
| Todd, EJ | 1 |
| Brown, AJ | 1 |
| Folegatti, PM | 1 |
| Ewer, KJ | 1 |
| Aley, PK | 1 |
| Angus, B | 1 |
| Becker, S | 1 |
| Belij-Rammerstorfer, S | 1 |
| Bellamy, D | 1 |
| Bibi, S | 1 |
| Bittaye, M | 1 |
| Clutterbuck, EA | 1 |
| Dold, C | 1 |
| Faust, SN | 1 |
| Finn, A | 1 |
| Flaxman, AL | 1 |
| Hallis, B | 1 |
| Heath, P | 1 |
| Jenkin, D | 1 |
| Lazarus, R | 1 |
| Makinson, R | 1 |
| Minassian, AM | 1 |
| Pollock, KM | 1 |
| Ramasamy, M | 1 |
| Robinson, H | 1 |
| Snape, M | 1 |
| Tarrant, R | 1 |
| Voysey, M | 1 |
| Green, C | 1 |
| Douglas, AD | 1 |
| Hill, AVS | 1 |
| Lambe, T | 1 |
| Gilbert, SC | 1 |
| Pollard, AJ | 1 |
| Ruano, FJ | 1 |
| Somoza Álvarez, ML | 1 |
| Haroun-Díaz, E | 1 |
| Vázquez de la Torre, M | 1 |
| López González, P | 1 |
| Prieto-Moreno, A | 1 |
| Torres Rojas, I | 1 |
| Cervera García, MD | 1 |
| Pérez Alzate, D | 1 |
| Blanca-López, N | 1 |
| Canto Díez, G | 1 |
| Aksan, F | 1 |
| Nelson, EA | 1 |
| Swedish, KA | 1 |
| Saheb Sharif-Askari, N | 1 |
| Saheb Sharif-Askari, F | 1 |
| Mdkhana, B | 1 |
| Al Heialy, S | 1 |
| Ratemi, E | 1 |
| Alghamdi, M | 1 |
| Abusnana, S | 1 |
| Kashour, T | 1 |
| Hamid, Q | 1 |
| Halwani, R | 1 |
| Abd-Elsalam, S | 1 |
| Esmail, ES | 1 |
| Khalaf, M | 1 |
| Abdo, EF | 1 |
| Medhat, MA | 1 |
| Abd El Ghafar, MS | 1 |
| Ahmed, OA | 1 |
| Soliman, S | 1 |
| Serangawy, GN | 1 |
| Alboraie, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I/II Study to Determine Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 in UK Healthy Adult Volunteers[NCT04324606] | Phase 1/Phase 2 | 1,090 participants (Actual) | Interventional | 2020-04-23 | Active, not recruiting | ||
| Antibody Response After COVID-19 Vaccination in Chronic Kidney Disease and Kidney Transplant Patients[NCT05057936] | 140 participants (Actual) | Observational | 2021-06-01 | Completed | |||
| A Prospective Study Comparing the Antibody Response of Subjects With Chronic Liver Disease to mRNA, Inactivated Virus and Adenovirus Vector COVID-19 Vaccines[NCT04775069] | Phase 4 | 232 participants (Actual) | Interventional | 2021-05-21 | Completed | ||
| Immunogenicity of the ChAdox1 n CoV-19 Vaccine Against SARS-CoV-2 With 12-dose Vials: an Interim Analysis[NCT04961385] | 60 participants (Actual) | Observational | 2021-04-01 | Completed | |||
| Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death[NCT04914832] | Phase 4 | 75,012 participants (Actual) | Interventional | 2021-08-30 | Completed | ||
| Evaluation of Silver Nanoparticles as an Oropharyngeal Product (Mouthwash) and Nasal Hygiene, by Health Personnel Working at the Tijuana General Hospital Exposed to Patients Diagnosed With Atypical Pneumonia Caused by SARS-CoV-2[NCT04894409] | 231 participants (Actual) | Interventional | 2020-04-24 | Completed | |||
| Serology Testing (Antibody Levels) With Time Following SARS-CoV-2 (Covid-19) Vaccinations in Residents of Nursing, Extended Care, and Over-55 Communities[NCT04944095] | 10,000 participants (Anticipated) | Observational | 2021-08-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for acetaminophen and Pneumonia, Viral
| Article | Year |
|---|---|
Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic.
Topics: Acetaminophen; Analgesia; Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Coronavirus Infe | 2020 |
2 trials available for acetaminophen and Pneumonia, Viral
| Article | Year |
|---|---|
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Topics: Acetaminophen; Adenoviruses, Simian; Adult; Analgesics, Non-Narcotic; Antibodies, Neutralizing; Anti | 2020 |
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COV | 2020 |
7 other studies available for acetaminophen and Pneumonia, Viral
| Article | Year |
|---|---|
Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?
Topics: Acetaminophen; Antipyretics; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ibuprofen; P | 2020 |
Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen.
Topics: Acetaminophen; Betacoronavirus; Coronavirus Infections; COVID-19; Gastroenterologists; Humans; Pande | 2020 |
COVID-19: thoughts at sunrise.
Topics: Acetaminophen; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Vira | 2020 |
Treating COVID-19 with colchicine in community healthcare setting.
Topics: Acetaminophen; Anti-Inflammatory Agents; Azithromycin; Betacoronavirus; Cohort Studies; Colchicine; | 2020 |
Impact of the COVID-19 pandemic in children with allergic asthma.
Topics: Acetaminophen; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Analgesics, | 2020 |
A COVID-19 patient with intense burning pain.
Topics: Acetaminophen; Analgesics; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Back Pain; | 2020 |
Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
Topics: Acetaminophen; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Cells, Cultured; Coronavir | 2020 |